FasL, on the other hand, a type-II transmembrane protein expressed on cytotoxic T cells and NK cells, belongs to the tumor necrosis factors (TNF), and its activation leads to cellular apoptosis, while its downregulation is exploited by cancer cells to survive and escape the surveillance of the immune system [79]. The gene discussed is TNF; the disease is cancer.